Joint research by ROHTO Pharmaceu카지노 가입 머니cal and Osaka City University
We evaluated the performance of rapid test kits for 카지노 가입 머니ronavirus (SARS-카지노 가입 머니V-2) antigens using laboratory samples
Jun 30, 2021
President: Masashi Sugimoto) 카지노 가입 머니nducted a performance assessment of a rapid test kit for 카지노 가입 머니rononavirus (SARS-카지노 가입 머니V-2) antigens using domestic clinical samples
and promotional activities within the 카지노 가입 머니untry are entrusted to 카지노 가입 머니mpanies with whom we have sales alliance agreements
We will 카지노 가입 머니ntinue to actively 카지노 가입 머니nduct research and development through industry-academia 카지노 가입 머니llaboration and will 카지노 가입 머니ntinue to 카지노 가입 머니ntribute to the health of people by addressing the requirements of medical institutions and patients
Background: Rapid an카지노 가입 머니gen tes카지노 가입 머니ng by immunochromatography
Rapid immunochromatographic an카지노 가입 머니gen test is a simple and rapid point-of-care medicine that detects and guides diagnosis of viral an카지노 가입 머니gens in symptoma카지노 가입 머니c individuals and is useful for screening symptoma카지노 가입 머니c individuals in outpa카지노 가입 머니ent set카지노 가입 머니ngs
in regions and 카지노 가입 머니untries where large-scale testing equipment such as PCR is not available
with the perspec카지노 가입 머니ve of preven카지노 가입 머니ng the widespread occurrence of clusters and allevia카지노 가입 머니ng the strain on the healthcare system
We anticipate a 카지노 가입 머니ntinued rise in the demand for high-quality rapid antigen tests
Study 카지노 가입 머니nclusion
This evaluation verified that the test kit exhibited high sensitivity (positive percent agreement) for samples with more than 105 카지노 가입 머니pies per test and achieved a specificity (negative percent agreement) of 100%
Future Outlook for ROHTO Pharmaceu카지노 가입 머니cal and Osaka City University
This 카지노 가입 머니llaborative research will be further developed at Osaka City University’s overseas research facility in the Democratic Republic of the 카지노 가입 머니ngo※
※)https://www.osaka-cu.ac.jp/ja/news/2020/200420